DISCLAIMER: This product is strictly for research use only. It is meant solely for laboratory testing and in vitro studies-not for use in or on humans or animals. All details provided on this site are for educational purposes. This item is not intended to be used as a drug, supplement, or cosmetic, and must not be misrepresented as such.

AOD-9604
AOD-9604 is a modified fragment of human growth hormone designed to target fat loss by activating the fat-burning portion of the GH molecule (176-191). It was developed for obesity treatment and promotes fat breakdown without raising blood sugar or systemic GH levels.
Quantity: 1
All peptides arrive in powdered form for stability.
Third-Party Verified Purity
Each batch is tested and certified to meet or exceed 99% purity standards.
Made in the USA
Produced in United States WHO/GMP and ISO 9001:2015 certified facilities.
Rigorous Quality Control
Double-tested to ensure the highest quality for the most effective research.
What is AOD-9604?
AOD-9604 is a modified fragment of human growth hormone (GH), specifically amino acids 176–191. It was developed to isolate the fat-burning effects of GH without its growth-promoting or blood sugar-altering properties. Research has focused on AOD-9604's potential to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat storage), especially in stubborn areas like visceral or abdominal fat.
Potential Benefits Shown in Studies
- Stimulating fat breakdown (lipolysis)
- Inhibiting fat formation (lipogenesis)
- Reducing body fat, especially abdominal fat
- Supporting metabolism without impacting blood sugar
- Aiding in weight management and body recomposition
- Improving cartilage repair and joint health in some studies
- Acting without significantly influencing IGF-1 or insulin
Mechanisms of Action
Unlike full-length GH, AOD-9604 works independently of the IGF-1 axis. It:
- Targets beta-adrenergic and GH receptors in adipose tissue
- Stimulates breakdown of stored fat (lipolysis)
- Blocks formation of new fat cells (lipogenesis)
- Does not affect insulin or blood sugar levels, making it metabolically safe
- Can be administered orally or via injection in research settings
Because it avoids many of the side effects associated with growth hormone, AOD-9604 is considered a safer fat-targeting peptide for study.
Molecular Structure of AOD-9604

Sequence
Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
Molecular Properties
AOD-9604 Research Highlights
Clinical studies show AOD-9604 reduces abdominal and visceral fat without elevating IGF-1 or causing systemic GH-like effects.
Unlike GH, AOD-9604 has no negative effect on insulin sensitivity or blood glucose, making it suitable for overweight individuals and those with metabolic concerns.
Oral forms of AOD-9604 have shown partial absorption and biological activity, potentially offering a more convenient delivery method.
In vitro research suggests AOD-9604 may also support cartilage regeneration and joint repair, opening the door for orthopedic uses.